Validated method for L-ornithine-L-aspartate analysis in human plasma by capillary electrophoresis

Biomedical Chromatography

Volumn 20, Issue 2, 2006, Pages 185-194

  Kowalski, P ^a   Bieniecki, M ^a   Oledzka, I ^a   Lamparczyk, H ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Capillary electrophoresis; Human plasma; L aspartic acid; L ornithine

Indexed keywords

AMINO ACIDS; BIOCHEMISTRY; PLASMA (HUMAN); SILICA; SODIUM BORATE; SODIUM BOROHYDRIDE; SODIUM HYDROXIDE;

AMINO-ACIDS; ASPARTATES; DERIVATIZATION PROCEDURES; GRADIENT PROCEDURE; HUMAN PLASMAS; L-ASPARTIC ACID; L-ORNITHINE; SAMPLE PREPARATION; SILICA CAPILLARY; VALIDATED METHODS;

CAPILLARY ELECTROPHORESIS;

ASPARTIC ACID; BORATE SODIUM; ORNITHINE; ORNITHINE ASPARTATE; SODIUM HYDROXIDE; THEOPHYLLINE;

ARTICLE; BLOOD SAMPLING; CAPILLARY ELECTROPHORESIS; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SEPARATION TECHNIQUE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ULTRAVIOLET SPECTROSCOPY; VALIDATION PROCESS;

EID: 32544452854     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.551     Document Type: Article

References (17)

1. Delcker A, Turowski B, Mihm U, Raab P, Rusch O, Pilatus U, Zeuzem S and Zanella FE. Proton MR spectroscopy of neurometabolites in hepatic encephalopathy during L-ornithine-L-aspartate treatment - results of a pilot study. Metabolic Brain Disease 2002; 17: 103-111.
2. Feher J, Lang I, Gogl A, Varga L, Varga L, Tompos G and Pronai L. Effect of ornithine-aspartate infusion on elevated serum ammonia concentration in cirrhotic patients - results of a randomized, placebo-controlled double-blind multicentre trial. Medical Science Monitor 1997; 3: 669-673.
3. Gatti R, Giola MG, Andreatta P and Pentassuglia G. HPLC-fluorescence determination of amino acids in pharmaceuticals after pre-column derivatization with phanquinone. Journal of Pharmaceutical and Biomedical Analysis 2004; 35: 339-348.
4. Gebhardt R, Beckers G, Gaunitz F, Haupt W, Jonitza D, Klein S and Scheja L. Treatment of cirrhotic rats with L-ornithine-L-aspartate enhances urea synthesis and lowers serum ammonia levels. Journal of Pharmacology and Experimental Therapeutics 1997; 283: 1-6.
5. Hodisan T, Culea M, Cimpoiu C and Cot A. Separation, identification and quantitative determination of free amino acids from plant extracts. Journal of Pharmaceutical and Biomedical Analysis 1998; 18: 319-323.
6. Izco JM, Tormo M and Jiménez-Flores R. Rapid simultaneous determination of organic acids, free amino acids, and lactose in cheese by capillary electrophoresis. Journal of Dairy Science 2002; 85: 2122-2129.
7. de Jonge LH and Breuer M. Evaluation of systematic errors due to deproteinization, calibration and storage of plasma for amino acid assay by ion-exchange chromatography. Journal of Chromatography B 1996; 677: 61-68.
8. Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Görtelmeyer R, Hendricks R, Krilger B, Kuklinski B, Meister H, Otto HJ, Rink C, Rösch W and Stauch S. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. Hepatology 1997; 25: 1351-1360.
9. Kircheis G, Wettstein M, vom Dahl S and Haussinger D. Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy. Metabolic Brain Disease 2002; 17: 453-462.
10. Rees CJ, Oppong K, Mardini HA, Hudson M and Record CO. Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial. Gut 2000; 47: 571-574.
11. Rose C, Michalak A, Rao KVR, Quack G, Kircheis G and Buttertworth RF. L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain oedema in rats with acute liver failure. Hepatology 1999; 30: 636-640.
12. Staedt U, Leweling H, Gladisch R, Kortsik C, Hagmüller and Holm E. Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover design. Journal of Hepatology 1993; 19: 424-430.
13. Stauch S, Kircheis G, Adler G, Beckh K, Ditschuneit H, Görtelmeyer R, Hendricks R, Heuser A, Karoff C, Malfertheiner P, Mayer D, Rösch W and Steffens J. Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study. Journal of Hepatology 1998; 28: 856-864.
14. Stenberg M, Marko-Varga G and Öste R. Enantioseparation of D- and L-amino acids by a coupled system consisting of an ion-exchange column and a chiral column and determination of D-aspartic acid and D-glutamic acid an in soy products. Food Chemistry 2002; 79: 507-512.
15. Vogels BAPM, Karlsen OT, Maas MAW, Boveé WMMJ and Chamuleau RAFM. L-Ornithine vs L-ornithine-L-aspartate as a treatment for hyperammonemia-induced encephalopathy in rats. Journal of Hepatology 1997; 26: 174-182.
16. Warren CR and Adams MA. Capillary electrophoresis for the determination of major amino acids and sugars in foliage: application to the nitrogen nutrition of sclerophyllous species. Journal of Experimental Botany 2000; 51: 1147-1157.
17. Yu H, Ding YS, Mou SF. Some factors affecting separation and detection of amino acids by high-performance anion-exchange chromatography with integrated pulsed amperometric detection. Journal of Chromatography A 2003; 997: 145-153.